RUBICON:NSE
Rubicon Research Ltd
1 520,00 ₹
arrow_downward
-1,31%(-20,20) 1K
13-okt, 15:30:00 (GMT+5:30) · INR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoRUBICON tikeri uchun statistika yaratilmoqda...
Ochish
1 540,20 ₹
Yuqori
1 549,80 ₹
Past
1 500,00 ₹
Bozor kapitali
251,61Â mlrd
Oʻrtacha hajm
239,19Â ming
Hajmi
198,62Â ming
Dividend
0,10%
Choraklik dividendlar
0,38 ₹
Eks-dividend sanasi
7-avg, 2026
P/E koeffitsiyenti
87,09
52 haftalik eng yuqori
1 899,00 ₹
52 haftalik eng past
570,75 ₹
Aksiya boʻyicha daromad
17,45 ₹
Xodimlar soni
1Â ming
Ochish
1 540,20 ₹
Yuqori
1 549,80 ₹
Past
1 500,00 ₹
Bozor kapitali
251,61Â mlrd
Oʻrtacha hajm
239,19Â ming
Hajmi
198,62Â ming
Dividend
0,10%
Choraklik dividendlar
0,38 ₹
Eks-dividend sanasi
7-avg, 2026
P/E koeffitsiyenti
87,09
52 haftalik eng yuqori
1 899,00 ₹
52 haftalik eng past
570,75 ₹
Aksiya boʻyicha daromad
17,45 ₹
Xodimlar soni
1Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Simply Wall Street
·
12 soat oldin
3 Indian Growth Stocks With ROE Above 22%
Profil
Rubicon Research is an Indian pharmaceutical company located in Mumbai.
The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US. Wikipedia
Rubicon Research Ltd haqida